Navigation Links
NicOx' Naproxcinod ABPM Data Presented at American Heart Association
Date:11/7/2007

se compounds in the reverse order. Subjects received a 2 week placebo wash-out before and in between the active treatment periods. Eligible subjects were between 50 and 75 years of age, in order to be representative of the osteoarthritis population, and 71.8% were over 65 years of age. Eligible subjects had controlled hypertension, defined as SBP inferior to 150 mmHg and/or DBP inferior to 95 mmHg and were treated for their hypertension by drugs from no more than 2 different antihypertensive drug classes at stable doses at screening. Eligible patients were not current NSAID users.

ABPM involves using a portable device to independently measure and record blood pressure at frequent intervals over a 24-hour period with minimal disruption of the subject's daily activity. In this trial, a 24-hour ABPM was performed at the start and following each of the two active treatment periods. During the 24-hour period, blood pressure measurements were taken at 20-minute intervals between 6:00 am and 10:00 pm and every hour from 10:01 pm to 5:59 am. In total four 24-hour ABPM measurements were taken per subject.

About naproxcinod

Naproxcinod, NicOx' lead investigational product, is in phase 3 clinical development for the treatment of the signs and symptoms of osteoarthritis. Results from the first pivotal phase 3 study (the 301 study) showed that naproxcinod has superior efficacy compared to placebo and no detrimental effect on blood pressure, in contrast to the existing anti-inflammatory agent naproxen. The two remaining pivotal phase 3 trials for naproxcinod are currently ongoing (302 and 303) and patients are undergoing standardized blood pressure measurements at each visit to the treatment center in these studies (Office Blood Pressure Measurements, OBPM). The Company expects to report the 302 and 303 efficacy results in mid-2008 and will conduct a predefined statistical analysis on the pooled OBPM data from the three phase 3 studies (301, 302 and 303), follow
'/>"/>

SOURCE NicOx S.A.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
2. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
5. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
6. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
7. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
8. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... MILFORD, Conn. , June 3, 2015 /PRNewswire/ ... of innovative access technologies for minimally invasive surgery ... the AirSeal® System in over 250,000 procedures.  Adoption ... global procedures over last year, driven by the ... market as well as geographic expansion to over ...
(Date:6/3/2015)... aTyr Pharma, Inc. (NASDAQ: LIFE ), a ... therapeutics to address rare diseases, today announced the Company,s participation ... Conference to be held at the Four Seasons Hotel in ... John Mendlein , aTyr,s CEO and Executive Chairman, ... 9:20 a.m. CT on Wednesday, June 10, 2015. The presentation ...
(Date:6/3/2015)... GAITHERSBURG, Md. , June 3, 2015  GenVec, ... collaboration with Dr. David T. Curiel and ... University at St. Louis (WUSTL).  ... Center and the Cancer Biology Division within the Department ... GenVec and the WUSTL team will create modified versions ...
Breaking Medicine Technology:Rapid Procedure Growth With SurgiQuest's AirSeal System 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4
... DAYTON, Ohio , Jan. 18 ...  active and passive containers for transporting temperature sensitive pharmaceutical ... a provider of active container solutions for the temperature ... controlled containers for use in shipping and storing blood, ...
... Mich., Jan. 7 Perrigo Company (Nasdaq: PRGO ; ... Papa will present at the 28th Annual J.P. Morgan Healthcare ... the Westin St. Francis Hotel in San Francisco. , ... manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, ...
Cached Medicine Technology:AcuTemp Thermal Systems and CSafe, LLC to Offer Temperature Controlled Containers to Aid in Relief Efforts in Haiti 2AcuTemp Thermal Systems and CSafe, LLC to Offer Temperature Controlled Containers to Aid in Relief Efforts in Haiti 3
(Date:6/3/2015)... “ Harmony ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... improve some aspect of their life. , A common mistake ... with difficulties in their life. However, hypnotherapy is intended for ...
(Date:6/3/2015)... June 03, 2015 On June 22, 2015, ... of genetic drug sensitivity (pharmacogenetic) testing that it has reimbursed ... as many as 19 million of the 49 million Medicare ... costly and life-threatening adverse drug events.(1) Sadly, if it became ... , Precision Medicine, the use of an individual’s genetic information ...
(Date:6/3/2015)... York, NY (PRWEB) June 03, 2015 Dr. ... New York Cardiac Diagnostic Center ( http://www.newyorkcardiac.com ) located in ... appointments on weekdays to his practice. In most cases, depending ... time of the day they call, they will be seen ... “My first priority as a cardiologist is to ensure that ...
(Date:6/3/2015)... DC (PRWEB) June 03, 2015 Alberto ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the Global Connector Award that annually recognizes one DIA ... has advanced the mission of DIA to foster innovation ...
(Date:6/3/2015)... Justina Molzon, MS Pharm, JD will be ... Annual Meeting. DIA’s Global Inspire Award program recognizes the ... and commitment to service on a global scale. ... Award that recognizes the “Member of the Year” who ... who has contributed to the advancement of DIA’s mission. ...
Breaking Medicine News(10 mins):Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3
... groundbreaking Healthy Kids Program offers tools for family ... estimated at $14 billion annually- Employers and health ... of its kind personalized solution that provides tools ... and helps parents and kids become healthierMARIETTA, Ga., ...
... get on the map. , ... Washington, DC -- ... fundraiser challenge today to raise money to send lifesaving bed nets ... killer of refugees. Supporters are holding hundreds of fundraisers across the ...
... to Deliver eBill and Attachment Support for ... PECOS, N.M. and CONCORD, Calif., April 1 ... processing company serving the medical community, and ... integrated eBill and payment compliance services to ...
... to demonstrate HL7 interoperability for the Department of Defense,s MiCare System at ... ... 2009 -- iNTERFACEWARE is pleased to announce that its Iguana ... IHE demonstration of MiCare at the HIMSS Convention in Chicago next week. ...
... Más Pequeño del Mundo se ha introducido por MiCigarrillo™. El ... millones de fumadores en todo el mundo. , ... ... fumadores son adictos a la nicotina que se encuentra en ...
... talk about it with your doctor, but if childbirth ... pelvic organs, you need to know help is possible. ... Southeast Urogynecology at Women,s Specialty Center in Jackson, Miss. ... the entire southeast performing minimally invasive laparoscopic surgery at ...
Cached Medicine News:Health News:New Online Program Helps Parents Tackle Childhood Obesity 2Health News:New Online Program Helps Parents Tackle Childhood Obesity 3Health News:Nothing But Nets Launches World Malaria Day Fundraising Challenge 2Health News:Nothing But Nets Launches World Malaria Day Fundraising Challenge 3Health News:CLAIM.MD Adds Jopari Workers' Compensation Connectivity 2Health News:Iguana Selected for Department of Defense IHE Demonstration at HIMSS 09 2Health News:Iguana Selected for Department of Defense IHE Demonstration at HIMSS 09 3Health News:Cigarrillo Electronico "Excelente 2009" Introducido por MiCigarrillo™ 2Health News:Cigarrillo Electronico "Excelente 2009" Introducido por MiCigarrillo™ 3Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 2Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 3Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 4
... Used for temporary internal ... to the bladder. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... Sof-Flex stents must not remain ...
... Used for temporary internal ... to the bladder. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... Sof-Flex stents must not remain ...
... instrument introduction. The dual knobs allow ... and removed. The maximum diameter of ... introduced should be measured to ensure ... sterile in peel-open packages. Intended for ...
... to provide urethral drainage ... repair. The C-shape allows ... close during postoperative swelling ... maintaining urethral patency. Supplied ...
Medicine Products: